UPDATE 1-FDA grants accelerated approval to Lilly's soft tissue sarcoma drug
October 19, 2016 at 15:20 PM EDT
Oct 19 (Reuters) - The U.S. Food and Drug Administration on Wednesday granted accelerated approval to Eli Lilly and Co's drug for treating adults with advanced soft tissue sarcoma (STS).
